Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.50
Bid: 3.30
Ask: 3.70
Change: 0.07 (2.04%)
Spread: 0.40 (12.121%)
Open: 3.55
High: 3.75
Low: 3.50
Prev. Close: 3.43
TERN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Court Meeting & GM & Lapsing of Scheme

21 Jul 2022 13:30

RNS Number : 3388T
Pires Investments PLC
21 July 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

FOR IMMEDIATE RELEASE

21 July 2022

Recommended All-Share Offer

for

Pires Investments plc ("Pires")

by

Tern plc ("Tern")

proposed to be implemented by means of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006

Results of Court Meeting and General Meeting and Lapsing of Scheme

On 1 June 2022, it was announced that the Tern Directors and Pires Directors had reached agreement on the terms of a recommended all-share offer by Tern for the issued and to be issued share capital of Pires, proposed to be effected by means of a court-sanctioned scheme of arrangement (the "Scheme") between Pires and Pires Shareholders under Part 26 of the Companies Act 2006 (the "Acquisition").

Earlier today, Pires convened the Court Meeting and General Meeting in connection with the Acquisition.

At the Court Meeting, 60 out of 75 Scheme Shareholders present and voting (whether in person or by proxy) voted in favour of the Scheme, representing 53.50 per cent. in value of the Scheme Shares. While the majority of Scheme Shareholders voting and present at the Court Meeting voted in favour of the Scheme, this did not meet the requirement that Scheme Shareholders voting and present at the Court Meeting representing 75 per cent. or more in value of the Scheme Shares held by such Scheme Shareholders must vote in favour of the Scheme.

At the General Meeting, 53.75 per cent. of the Pires Shareholders present and voting (whether in person or by proxy) voted in favour of the Special Resolution, which was below the minimum threshold (75 per cent. of those shares voted) needed to approve the Special Resolution.

Accordingly, certain of the conditions to the Scheme were not satisfied and the Scheme has lapsed.

The Court Hearing to sanction the Scheme, which was expected to be held on or around 28 July 2022, will now not take place.

As a result, Pires is no longer in an offer period as defined by the City Code on Takeovers and Mergers (the "Code").

Voting results of the Court Meeting

The table below sets out the results of the poll at the Court Meeting. Each Scheme Shareholder, present in person or by proxy, was entitled to one vote per Scheme Share held at the Voting Record Time.

 

Results of Court Meeting

No. of Scheme Shares voted

% of Scheme Shares voted*

No. of Pires Shareholders who voted

% of Pires Shareholders who voted*

No. of Scheme Shares voted as % of issued share capital*

For

53,813,889

53.50%

60

80.00%

31.57%

Against

46,765,049

46.50%

15

20.00%

27.44%

Total

100,578,938

-

75

-

59.01%

* Rounded to two decimal places

Voting results of the General Meeting

The table below sets out the results of the poll at the General Meeting. Each Pires Shareholder, present in person or by proxy, was entitled to one vote per Pires Share held at the Voting Record Time.

 

For**

Against

Total

Special resolution

No. of votes

% of votes*

No. of votes

% of votes*

No. of votes

Approval of the implementation of the Scheme

68

53.75%

15

46.25%

100,822,109

Amendments to the articles

68

53.75%

15

46.25%

100,822,109

Re-registration as a private company

67

53.74%

16

46.26%

100,822,109

* Rounded to two decimal places

** Includes discretionary votes

 

The total number of Pires Shares in issue at the Voting Record Time was 170,456,642. Consequently, the total voting rights in Pires at the Voting Record Time were 170,456,642.

Capitalised terms used but not otherwise defined in this announcement have the meanings given to them in the Scheme Document published on 28 June 2022 in relation to the Acquisition.

 

 

Enquiries:

 

Pires Investments plc

Nicholas Lee, Non-Executive Director

 

+44 (0) 20 3368 8961

Cairn Financial Advisers LLP

Financial Adviser, Rule 3 Adviser and Nominated Adviser to Pires

James Lewis / Liam Murray / Ludovico Lazzaretti

 

+44 (0) 20 7213 0880

Peterhouse Capital Limited

Joint Broker to Pires

Duncan Vasey / Lucy Williams

 

+44 (0) 20 7469 0935

Tennyson Securities

Joint Broker to Pires

Peter Krens

 

+44 (0) 20 3167 7221

Yellow Jersey PR

PR advisers to Pires

Sarah Hollins / Henry Wilkinson / Annabelle Wills

 

+44 (0) 20 3004 9512

 

Notices related to the financial adviser

Cairn, which is authorised and regulated by the FCA in the UK, is acting as financial adviser and Rule 3 adviser exclusively for Pires and no one else in connection with the Acquisition and the matters set out in this announcement and will not be responsible to any person other than Pires for providing the protections afforded to clients of Cairn, nor for providing advice in relation to the Acquisition, the content of this announcement or any matter referred to herein. Cairn's responsibilities as Pires' Nominated Adviser under the AIM Rules for Companies and AIM Rules for Nominated Advisers are owed solely to London Stock Exchange and no other person. Cairn has not authorised and is not making any representation or warranty, express or implied, as to the contents of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBDGDRSBDDGDB
Date   Source Headline
22nd Jun 20189:05 amRNSSecond Price Monitoring Extn
22nd Jun 20189:00 amRNSPrice Monitoring Extension
22nd Jun 20187:01 amEQSTern PLC: DA Security Blueprint
18th Jun 20187:00 amEQSTern PLC: Issue of Equity
14th Jun 20184:40 pmRNSSecond Price Monitoring Extn
14th Jun 20184:35 pmRNSPrice Monitoring Extension
14th Jun 20189:00 amRNSPrice Monitoring Extension
13th Jun 20184:40 pmRNSSecond Price Monitoring Extn
13th Jun 20184:35 pmRNSPrice Monitoring Extension
13th Jun 20182:06 pmRNSSecond Price Monitoring Extn
13th Jun 20182:00 pmRNSPrice Monitoring Extension
13th Jun 201812:46 pmEQSTern PLC: Statement re: Share Price Movement
13th Jun 201811:05 amRNSSecond Price Monitoring Extn
13th Jun 201811:00 amRNSPrice Monitoring Extension
12th Jun 201811:00 amRNSPrice Monitoring Extension
12th Jun 20187:00 amEQSTern PLC: DA Launches KeyScaler SaaS
11th Jun 20189:06 amRNSSecond Price Monitoring Extn
11th Jun 20189:00 amRNSPrice Monitoring Extension
11th Jun 20187:00 amEQSTern PLC: Issue of Loan to Device Authority
8th Jun 201810:15 amEQSTern PLC: Statement re: Share Price Movement
30th May 20189:03 amEQSTern PLC: Holdings in Company
22nd May 20187:00 amEQSTern PLC: DA Strategic Partnerships with SyroCon Consulting and EonTi
16th May 20187:00 amEQSTern PLC: Portfolio Update
14th May 20187:00 amEQSTern PLC: Raises £700,000 and Acquires Stake in Medical VR Company
8th May 20187:01 amEQSTern PLC: Equity Fundraise
3rd May 20187:00 amEQSTern PLC: GCE Healthcare Launches Platform Developed by InVMA to Market
30th Apr 20189:05 amEQSTern PLC: Update following the Shareholder Conference Call
25th Apr 20187:06 amEQSTern PLC: Additional Investment in InVMA
24th Apr 20184:41 pmRNSSecond Price Monitoring Extn
24th Apr 20184:35 pmRNSPrice Monitoring Extension
24th Apr 20183:25 pmEQSTern PLC: Result of AGM
24th Apr 20187:02 amEQSTern PLC: DA extends Microsoft Azure IoT hub security capabilities
19th Apr 20185:04 pmEQSTern PLC: Holdings in Company
18th Apr 201810:06 amEQSTern PLC: Holdings in Company
13th Apr 20187:02 amEQSTern PLC: Shareholder Conference Call
10th Apr 20187:02 amEQSTern PLC: DA and InVMA Complete integration of KeyScaler and AssetMinder
6th Apr 20181:38 pmEQSTern PLC: Holdings in Company
6th Apr 20189:05 amRNSSecond Price Monitoring Extn
6th Apr 20189:00 amRNSPrice Monitoring Extension
5th Apr 201810:00 amEQSTern PLC: Update on Device Authority loan
4th Apr 20187:02 amEQSTern PLC: DA Strategic Partnership with Gemalto
27th Mar 20187:02 amEQSFinal results for the year ended 31 December 2017
26th Mar 20182:05 pmRNSSecond Price Monitoring Extn
26th Mar 20182:00 pmRNSPrice Monitoring Extension
23rd Mar 20187:02 amEQSTern PLC: Holdings in Company
13th Mar 20182:37 pmEQSTern PLC: Holding(s) in Company
13th Mar 20182:12 pmEQSTern PLC: Holdings in Company
13th Mar 20186:02 amEQSTern PLC: Update on DA Strategic Partnership
24th Jan 201811:05 amRNSSecond Price Monitoring Extn
24th Jan 201811:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.